Elio Mazzone, MD

About Elio Mazzone, MD

Elio Mazzone, MD, With an exceptional h-index of 31 and a recent h-index of 30 (since 2020), a distinguished researcher at Università Vita-Salute San Raffaele, specializes in the field of Urologic oncology, Minimally invasive surgery, Biostatistics, Surgical training.

His recent articles reflect a diverse array of research interests and contributions to the field:

MP56-15 CLINICAL CHARACTERISTICS OF PATIENTS WITH RENAL CANCER DO IMPACT MORE THAN ISCHEMIA TIME ON POST-OPERATIVE RENAL FUNCTION

MP14-15 WHICH IS THE OPTIMAL MULTIMODAL MANAGEMENT OF PN1 PATIENTS WITH PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY AND EXTENDED NODAL DISSECTION? RESULTS OF A LARGE, MULTI …

MP05-20 WHOLE EXOME SEQUENCING ANALYSIS IN LOW-RISK PROSTATE CANCER PATIENTS WITH KNOWN FAMILY HISTORY. IMPLICATION FOR ACTIVE SURVEILLANCE

PD61-04 LONG-TERM ONCOLOGICAL OUTCOMES OF SURGICALLY MANAGED VERY HIGH-RISK PROSTATE CANCER PATIENTS ACCORDING TO THE STAMPEDE TRIAL DEFINITION: IMPLICATIONS FOR THE SELECTION …

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology

Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Versatility of Single Port Retroperitoneal Low Anterior Access: early outcomes in multiple procedures

Intraoperative image-guidance during robotic surgery: is there clinical evidence of enhanced patient outcomes?

Elio Mazzone, MD Information

University

Position

Resident . Former fellow at CHUM and OLV hospital.

Citations(all)

2945

Citations(since 2020)

2887

Cited By

796

hIndex(all)

31

hIndex(since 2020)

30

i10Index(all)

81

i10Index(since 2020)

80

Email

University Profile Page

Google Scholar

Elio Mazzone, MD Skills & Research Interests

Urologic oncology

Minimally invasive surgery

Biostatistics

Surgical training

Top articles of Elio Mazzone, MD

MP56-15 CLINICAL CHARACTERISTICS OF PATIENTS WITH RENAL CANCER DO IMPACT MORE THAN ISCHEMIA TIME ON POST-OPERATIVE RENAL FUNCTION

The Journal of Urology

2024/5

MP14-15 WHICH IS THE OPTIMAL MULTIMODAL MANAGEMENT OF PN1 PATIENTS WITH PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY AND EXTENDED NODAL DISSECTION? RESULTS OF A LARGE, MULTI …

The Journal of Urology

2024/5

MP05-20 WHOLE EXOME SEQUENCING ANALYSIS IN LOW-RISK PROSTATE CANCER PATIENTS WITH KNOWN FAMILY HISTORY. IMPLICATION FOR ACTIVE SURVEILLANCE

The Journal of Urology

2024/5

PD61-04 LONG-TERM ONCOLOGICAL OUTCOMES OF SURGICALLY MANAGED VERY HIGH-RISK PROSTATE CANCER PATIENTS ACCORDING TO THE STAMPEDE TRIAL DEFINITION: IMPLICATIONS FOR THE SELECTION …

The Journal of Urology

2024/5

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology

World Journal of Urology

2024/4/22

Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

European urology

2024/4/16

Versatility of Single Port Retroperitoneal Low Anterior Access: early outcomes in multiple procedures

Journal of Endourology

2024/4/13

Intraoperative image-guidance during robotic surgery: is there clinical evidence of enhanced patient outcomes?

2024/4/12

Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer

The Prostate

2024/4

Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a …

European Urology Oncology

2024/4/1

Identifying low cancer‐specific mortality risk lymph node‐positive radical prostatectomy patients

Journal of Surgical Oncology

2024/3/12

Whole exome sequencing analysis in low-risk prostate cancer patients with known family history. Implication for active surveillance

European Urology

2024/3/1

INTEGRATING PSMA EXPRESSION PATTERNS, MORPHOLOGICAL AND CLINICAL FEATURES TO OPTIMIZE DETECTION OF NODAL METASTASES IN PATIENTS TREATED WITH PSMA RADIO-GUIDED ROBOT-ASSISTED …

2024/1/15

MP19-07 TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI …

The Journal of Urology

2024/5

PD57-10 AGE-DEPENDENT EFFECT OF EARLY SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY

The Journal of Urology

2024/5

MP37-20 THE EFFECT OF PENILE REHABILITATION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ON URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY. RESULTS FROM a HIGH-VOLUME, SINGLE …

The Journal of Urology

2024/5

MP73-11 TRAIN THE TRAINERS FOR THE DELIVERY OF PROFICIENCY BASED PROGRESSION TRAINING BY THE EUROPEAN ROBOTIC SURGICAL SECTION FELLOWSHIP CENTERS

The Journal of Urology

2024/5

Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series

European Urology Oncology

2023/10/1

MP67-07 CAN WE PREDICT THE SITE OF POSITIVE SURGICAL MARGINS (PSM) BASED ON THE SITE OF THE INDEX LESION AT MULTIPARAMETRIC MRI? A TOPOGRAPHIC SINGLE CENTER STUDY

The Journal of Urology

2023/4

MP40-14 ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?

The Journal of Urology

2023/4

See List of Professors in Elio Mazzone, MD University(Università Vita-Salute San Raffaele)